Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Shares Outstanding for 16 consecutive years, with $15.0 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 7.2% to $15.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2025, up 7.2% year-over-year, with the annual reading at $15.0 million for FY2025, 7.2% up from the prior year.
  • Shares Outstanding hit $15.0 million in Q4 2025 for Cumberland Pharmaceuticals, roughly flat from $15.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $15.1 million in Q1 2021 to a low of $14.0 million in Q4 2024.
  • Historically, Shares Outstanding has averaged $14.6 million across 5 years, with a median of $14.6 million in 2022.
  • Biggest five-year swings in Shares Outstanding: fell 2.73% in 2023 and later grew 7.2% in 2025.
  • Year by year, Shares Outstanding stood at $14.7 million in 2021, then fell by 2.55% to $14.4 million in 2022, then fell by 1.7% to $14.1 million in 2023, then fell by 1.2% to $14.0 million in 2024, then rose by 7.2% to $15.0 million in 2025.
  • Business Quant data shows Shares Outstanding for CPIX at $15.0 million in Q4 2025, $15.0 million in Q3 2025, and $15.0 million in Q2 2025.